**Core tip:** This is one of the largest published series describing the management of difficult biliary stone disease utilizing large balloon sphincteroplasty in a Western population. Our findings suggest that large balloon sphincteroplasty can be performed and repeated safely and effectively in those with a sphincterotomy irrespective of its timing and size to establish complete duct clearance.

INTRODUCTION
============

Common bile duct stones (CBDS) are diagnosed frequently throughout the world. The prevalence of CBDS in symptomatic gallstone disease is estimated between 10% and 20%\[[@B1]-[@B3]\]. Extraction of confirmed CBDS in symptomatic patients is recommended\[[@B4]\]. Endoscopic retrograde cholangiopancreatography (ERCP) is recognized as an effective treatment modality for CBDS extraction. Endoscopic sphincterotomy (EST) followed by stone extraction with balloon or basket has been used traditionally as a standard technique. Large or multiple stones however, may be technically challenging with standard techniques and may require additional treatment modalities including mechanical lithotripsy for successful stone extraction\[[@B5]-[@B7]\].

Endoscopic papillary balloon dilatation (EPBD) for biliary stones extraction was first reported in 1982\[[@B8]\]. EPBD without an EST has been reported but is associated with an increased risk of pancreatitis and reduced stone clearance rates\[[@B9]\]. In a Cochrane review, EPBD compared to EST has been associated with less risk of bleeding but increased risk of post ERCP pancreatitis\[[@B10]\].

EST followed by endoscopic papillary large balloon dilatation (EST+EPLBD) using a balloon sized 10-20mm was reported in 2003 as an effective and safe treatment of CBDS\[[@B11]\]. EPLBD with limited or full EST has subsequently emerged as an established endoscopic technique in the management of CBDS mainly in Asia based on published data\[[@B12]\]. Interestingly, more recent data has suggested that endoscopic papillary large balloon dilatation (EPLBD) alone without a preceding EST is a useful technique in CBDS removal with comparable outcomes to EST\[[@B13],[@B14]\].

The safety profile and effectiveness of EPLBD with limited or full EST has been reported in most studies\[[@B15]-[@B27]\]. However, concerns remain regarding serious adverse events\[[@B28]-[@B32]\] including procedure related morbidity and mortality limiting wider application of EPLBD in the management of CBDS.

There remains a significant variation in practice when performing large balloon papillary dilatation with particular concerns to the timing and size of sphincterotomy prior to balloon dilatation. This study describes the safety profile and effectiveness of EPLBD in the management of CBDS and examines the impact of timing and size of sphincteroplasty in relation to EST in a Western population.

MATERIALS AND METHODS
=====================

Patients
--------

This study from a United Kingdom academic referral centre involved 229 patients who had EPLBD for retrieval of CBDS from 1^st^ August 2009 to 31^st^ July 2015. Of these, 115 (50%) patients had previous unsuccessful stone extraction elsewhere. Inclusion criteria were: adult patients with confirmed CBDS and who gave consent for the procedure. Excluded from the study were patients with coagulopathy (INR \> 1.5), thrombocytopenia (platelet count \< 50000/mL), and those who had distal biliary stricture.

Procedure
---------

ERCP was undertaken predominantly with benzodiazepine and opioid sedation. General anesthesia was used when per-oral cholangioscopy (POC) (SpyGlass^TM^DS, Boston Scientific, MA, United States) was performed.

ERCP was performed using side-viewing endoscopes (TJF-240; Olympus Optical Corporation, Tokyo, Japan). Standard wire guided EST was performed for native papilla. Stone extraction was attempted with extractor balloon catheter (Extractor^TM^ Pro RX, 2 lumen extraction balloon, Boston Scientific, Cork, Ireland and/or Multi-3V Plus^TM^, three lumen extraction balloon, Olympus Medical systems, Tokyo, Japan) and/or wire guided retrieval basket (Trapezoid^TM^, Boston Scientific Limited, Ireland).

Where stone retrieval was unsuccessful with standard techniques, EPLBD (CRE^TM^ Wire guided, Boston Scientific, Cork, Ireland) was performed for stone extraction. The balloon was inflated until disappearance of the waist (Figure [1](#F1){ref-type="fig"}). For complex and large stones, POC supplemented with electrohydraulic lithotripsy (EHL) (Nortech Autolith, Intracorporeal Electrohydraulic Lithotripter, Northgate Technologies INC, IL, United States) was used for stone extraction. Duct clearance was confirmed with an occlusion cholangiogram. Stone number, size and bile duct diameter were assessed with calibrated hospital radiology software tools on captured fluoroscopic images for accurate precision.

![Demonstration of endoscopic papillary large balloon dilatation. A: Fluoroscopic view showing balloon waist with a proximal stone; B: Endoscopic view of ampullary orifice while performing EPLBD; C: Demonstration of disappearance of balloon waist with gradual inflation of balloon.](WJG-23-8597-g001){#F1}

Study endpoints
---------------

The primary endpoint was common bile duct clearance. Secondary endpoints were procedure related adverse events (pancreatitis, bleeding, cholangitis, perforation and mortality).

Study design and statistical analysis
-------------------------------------

This was a cross-sectional study in which consecutive patients who underwent EPLBD during the defined period were evaluated based on study endpoints. Statistical analyses were performed using MedCalc for Windows, version 12.5 (MedCalc Software, Ostend, Belgium). Simple statistical applications were applied in order to determine whether significant differences exist in comparison groups. We initially used simple proportions to describe the study populations. Furthermore, we used chi-square test to compare proportions and categorical variables. Non-parametric Mann-Whitney *U*-test was applied in order to compare continuous variables. All comparisons were deemed to be statistically significant if *P* values were less than 0.05.

RESULTS
=======

Two hundred and twenty-nine subjects (146, females) fulfilled the inclusion criteria (Table [1](#T1){ref-type="table"}). Of these, 166 (72.5%) achieved duct clearance at index ERCP. In order to determine factors associated with duct clearance at index ERCP, subjects were divided into 2 groups according to duct clearance (A) and those who failed clearance (B). Only female gender was associated with failed duct clearance at index ERCP (*P* = 0.046).

###### 

Clinical characteristics by common bile duct clearance at the index endoscopic retrograde cholangiopancreatography *n* (%)

  **Variables**   **Group A (*n* = 166)**   **Group B (*n* = 63)**   ***P* value**
  --------------- ------------------------- ------------------------ ---------------
  Mean age        68.4 ± 14.3               68.4 ± 14.1              0.93
  Sex (M: F)      70:96                     17:46                    0.046
  HTN             65 (39.2)                 26 (41.3)                0.88
  IHD             19 (11.4)                 7 (11.1)                 0.87
  DM              14 (8.4)                  4 (6.3)                  0.80
  CLD             1 (0.6)                   None                     0.60
  COPD            16 (9.6)                  5 (7.9)                  0.89
  CKD             7 (4.2)                   2 (3.2)                  0.98

Large stone size, multiple stones and dilated common bile duct were significant predictors of failed duct clearance at index ERCP (Table [2](#T2){ref-type="table"}). Overall median balloon diameter used was 13.5 (10-18) mm (Table [3](#T3){ref-type="table"}).

###### 

Outcome of index endoscopic retrograde cholangiopancreatography by stone characteristics and anatomical features of the biliary tree n (%)

  **Variables**                                             **Group A (*n* = 166)**   **Group B (*n* = 63)**   ***P* value**
  --------------------------------------------------------- ------------------------- ------------------------ ---------------
  Number of stones                                          2 (1-13)                  3 (1-12)                 0.006
  Median diameter of stones (mm)                            12.4 (4.5-30)             17.4 (10.1-32)           \< 0.000001
  Median diameter of duct (mm)                              12.4 (5-30)               18.3 (9.2-30)            0.001
  Ampullary or peri-ampullary diverticulum                  37 (22.3)                 10 (15.9)                0.370
  Intact GB                                                 117 (70.5)                50 (79.4)                0.240
  Primary stone disease                                     118 (71.1)                44 (69.8)                0.980
  Recurrent stone disease[1](#T2FN1){ref-type="table-fn"}   48 (28.9)                 19 (30.2)                0.900

Recurrent stones were after previous EST.

###### 

Diameter of the balloon used

  **Balloon size**   ***n***   **Percent**
  ------------------ --------- -------------
  10-11 mm           62        27%
  12-15 mm           139       61%
  16-18 mm           28        12%

EST was performed at index ERCP in 81 (35.4%) and had previously been performed in 148 (64.6%) patients. Procedure time was significantly prolonged in those who failed to achieve duct clearance at index ERCP (30.5 min *vs* 44 min, *P* \< 0.001) (Table [4](#T4){ref-type="table"}).

###### 

Procedure characteristics by outcomes of common bile duct stone extraction *n* (%)

  ------------------------------ ------------------------- ------------------------ ---------------
  **Variables**                  **Group A (*n* = 166)**   **Group B (*n* = 63)**   ***P* value**
  Procedure time (min)           30.5 (9-160)              44 (12-90)               0.0010
  Number of ERCP (median)        1 (1-3)                   2 (1-10)                 0.0001
  Pre-cut sphincterotomy         6 (3.6)                   2 (3.2)                  0.8000
  Previous Sphincterotomy        106 (63.9)                42 (66.7)                0.8000
  Fresh Sphincterotomy           58 (35.5)                 23 (36.5)                0.9800
  Median Balloon size diameter   13 (10-18)                13.5 (10-18)             0.2200
  ------------------------------ ------------------------- ------------------------ ---------------

POC supplemented with EHL was the most commonly used additional treatment modality for stone extraction at index and subsequent ERCPs (Figures [2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"}).

![Types of additional therapy to endoscopic papillary large balloon dilatation at index endoscopic retrograde cholangiopancreatography for stone extraction. ML: Mechanical lithotripsy; POC: Per-oral cholangioscopy; EHL: Electrohydraulic lithotripsy.](WJG-23-8597-g002){#F2}

![Types of endoscopic interventions at subsequent endoscopic retrograde cholangiopancreatography in those with failed duct clearance at index endoscopic retrograde cholangiopancreatography. EPLBD: Endoscopic papillary large balloon dilatation; ML: Mechanical lithotripsy; POC: Per-oral cholangioscopy; EHL: Electrohydraulic lithotripsy.](WJG-23-8597-g003){#F3}

Initial duct clearance rate with EPLBD at index ERCP was 72.5%. However, all cases of failed duct clearance (Group B) at index ERCP underwent further ERCP for duct clearance. Final duct clearance rate was 97.8%.

The procedure related adverse events are listed in Table [5](#T5){ref-type="table"}. Post ERCP pancreatitis and haemorrhage were not significantly different between groups. There was no case of procedure related mortality.

###### 

Adverse events after endoscopic papillary large balloon dilatation *n* (%)

  **Variables**   **Group A (*n* = 166)**   **Group B (*n* = 63)**   ***P* value**
  --------------- ------------------------- ------------------------ ---------------
  Pancreatitis    0                         2 (3.2)                  0.13
  Bleeding        2 (1.2)                   0                        0.93
  Cholangitis     None                      None                     NA
  Perforation     None                      None                     NA
  Mortality       None                      None                     NA

DISCUSSION
==========

We report an experience of EPLBD based on intention to treat analysis from an academic United Kingdom endoscopy centre. The study shows that EST followed by immediate or delayed EPLBD (EST + EPLBD) is a safe and an effective approach. Duct clearance was achieved in 73% of the patients at index ERCP and further procedures produced an overall duct clearance rate of 98%. Procedure related complications were reported in only four patients (1.7%). EPLBD was performed immediately after sphincterotomy in 35% of the patients. The study results reveal comparable and even lower rates of complications including pancreatitis, perforation and bleeding than previously reported\[[@B10],[@B28]-[@B30],[@B32]\].

This is probably the largest single centre study in a Western population reporting the use of endoscopic large volume balloon dilatation in managing CBDS, in which 229 patients were included. A recent literature review reported data from 32 studies across the globe\[[@B12]\]. The largest study of this review, which was from China, included 169 patients.

In contrast to other published series reporting higher initial duct clearance rates, we observed relatively lower duct clearance rates at index ERCP. The reason for this is related to the more complex nature of stone disease in a referral population. Complexity of the stone disease in our cohort may be evident with the fact that all patients required large balloon sphincteroplasty in addition to the standard endoscopic techniques for stone extraction at the index ERCP. In addition to EPLBD using POC together with EHL could not achieve duct clearance in (3.5%) of patients at the index ERCP (Figure [2](#F2){ref-type="fig"}). Furthermore, 45% of the patients undergoing repeat ERCP for duct clearance required POC and EHL (Figure [3](#F3){ref-type="fig"}).

50% of the patients with first EPLBD performed at our centre had previously failed stone extraction with standard endoscopic techniques including EST followed by stone extraction with balloon and basket performed by the referring unit. Among those 50% with previous unsuccessful stone extraction, complete duct clearance was achieved with EPLBD in approximately 70% of the cases at index ERCP. Patients with failed duct clearance at index ERCP had significantly large stone size 17.4 (10.1-32) mm *vs* 12.4 (4.5-30) mm, *P* \< 0.000001, multiple stones \[2, range (1-13) *vs* 3, range (1-12), *P \<* 0.006\] and dilated bile duct 18.3 mm (9.2-30) mm *vs* 12.4 mm (5-30), *P* \< 0.001.

In a systemic review and meta-analysis\[[@B33]\] initial duct clearance rates for stones larger than 15mm was 77% in the EPLBD group. Initial duct clearance rates with EST + EPLBD vary from 72.7% to 100% in published series\[[@B12]\] which are mainly from Asia. In a recent study from Australia\[[@B34]\] initial duct clearance rates were 70% in immediate EPLBD group and 74% in delayed EPLBD group.

Major adverse events (AEs) related to EST and EPLBD are pancreatitis, bleeding, and perforation. A recent Australian retrospective study\[[@B34]\] reviewed outcomes of EPLBD and EST in 136 patients. Only one case of non-fatal pancreatitis and a perforation was observed in the delayed EPLBD group. Three cases of non-fatal haemorrhage were observed in immediate and delayed EPLBD group (*P* = 0.303). The safety profile of EPLBD has been corroborated by a recent meta-analysis\[[@B33]\] in which four randomized controlled trials (RCT) comparing EST plus EPLBD *vs* EST alone and EST plus mechanical lithotripsy were assessed. In the three RCTs comparing EPLBD with EST alone there were no statistical differences in terms of each form of adverse events: PEP (3% *vs* 3.4%); haemorrhage (0.5% *vs* 1%); cholangitis (1.5% *vs* 1.9); perforation (0% *vs* 1%). In the RCT comparing EPLBD with EST plus ML higher rates of cholangitis were observed 0% *vs* 13.3 (*P* = 0.026). In one of these RCTs\[[@B23]\] less overall adverse events were observed with EST + EPLBD than after EST alone (4.4% *vs* 20%, *P* = 0.049). This emphasises the safety profile of EPLBD.

A review of 32 studies involving 1761 patients, demonstrated overall rates of AEs related to EST combined with EPLBD including perforation, pancreatitis, bleeding and cholangitis were 0.4%, 2.7%, 2.2% and 0.9% respectively\[[@B12]\]. A retrospective multicenter study\[[@B28]\] investigating 946 patients reported 9 perforations (0.95%), resulting in 3 deaths. Distal CBD stricture (OR = 17.08, *P* \< 0.001) was an independent predictor for perforation. In a systemic review of 30 studies\[[@B35]\] the overall AEs were significantly lower in EST combined with EPLBD group than in EST alone (8.3% *vs* 12.7%, OR = 1.60, *P* \< 0.001).

Our AEs rates were not only comparable but even much lower than most of the published data. Pancreatitis was defined according to the consensus criteria described elsewhere. The overall pancreatitis rate in our cohort was 2/229 (0.87%). Both cases had non-fatal pancreatitis and were managed conservatively. In both these cases duct clearance was not achieved at index ERCP with EPLBD. This is one of the principal emphases of the study that in our experience EPLBD was not associated with significantly increased risk of post ERCP pancreatitis. Peri-procedural optimization of patients is our standard practice to prevent post ERCP pancreatitis. This includes providing adequate intravenous hydration, prescribing rectal diclofenac and keeping a low threshold for placement of pancreatic stents for contrast injection and wire cannulation of pancreatic duct. These preventive measures along with rich high volume experience are probably the principal factors for a very low rate of post ERCP pancreatitis. Similarly, 2 cases (0.87%) of gastrointestinal haemorrhage were observed. One patient required blood transfusion and endoscopic haemostatic therapy. The other patient required two units of blood transfusion. There was no procedure related perforation, cholangitis or mortality.

Twenty percent of the patients in our study had periampullary diverticula (PAD), which did not impact on the incidence of the adverse events or duct clearance. In patients with and without PAD, overall duct clearance and adverse events rates were similar in retrospective studies\[[@B24],[@B36]\] comparing EPLBD with limited EST or EPLBD alone.

In our study, the balloon was inflated until the disappearance of the waist rather than specific time duration. Hence, the balloon inflation time would have been relatively short. A meta-analysis\[[@B37]\] has reported an inverse relation of pancreatitis with balloon timing but this clearly was not the case in our scenario.

POC and EHL were planned in addition to EPLBD in 35 (15.3%) of the patients at index ERCP in view of previously demonstrated complex stone disease on cholangiographic appearances. In 8 (3.5%) patients, EPLBD even supplemented with POC and EHL could not clear the bile ducts due to complex nature of stone disease at index ERCP.

Prior to the introduction of EPLBD, ML was generally used after EST. In these circumstances, ML is traditionally used after EST. However, it may be time consuming and technically challenging with an increase risk of procedure related adverse events\[[@B23]\]. In our practice, EPLBD was the preferred treatment modality over ML and limited its use to 7% of the procedures. Recently published international consensus guidelines for EPLBD reaffirm our findings and recommend its use as preferred and alternative modality to ML in removing large bile duct stones\[[@B38]\].

Our experience of EST with immediate or delayed large balloon dilatation confirms its safety and effectiveness. We conclude that the safety of large balloon sphincteroplasty is not influenced by the presence of a periampullary diverticulum or a fresh sphincterotomy. Limited or full sphincterotomy followed by EPLBD does not influence the outcomes. Our results suggest that a significant proportion of patients with multiple stones and large stones may require additional treatment modalities including cholangioscopy and EHL where large balloon sphincteroplasty remains unsuccessful in achieving duct clearance.

ARTICLE HIGHLIGHTS
==================

Research background
-------------------

Endoscopic papillary large balloon dilatation (EPLBD) is an established technique for biliary stone extraction mainly in Asia. Serious adverse events related to EPLBD including pancreatitis, bleeding and perforation have limited its wider utility particularly in the Western world. Timing and size of preceding endoscopic sphincterotomy (EST) impose significant concerns regarding serious procedure related adverse events. This study describes the safety and efficacy of EPLBD in the management of CBDS and examines the impact of timing and size of sphincteroplasty in relation to EST in a Western population.

Research motivation
-------------------

EPLBD is being performed very frequently in day to day practice. There is insufficient data on its efficacy and safety without any standardized techniques. There is little data on timing and hence an appreciation that there is variation in practice in some centres performing a sphincteroplasty on a subsequent and further endoscopic retrograde cholangiopancreatography. The principal motive of the study was to ascertain whether EPLBD could be performed safely as an effective and preferred endoscopic modality for complex biliary stone extraction following EST.

Research objectives
-------------------

The main objectives of the study were to describe the efficacy and safety of EPLBD in the management of bile duct stones in a Western population from the experience in a busy tertiary referral unit.

Research methods
----------------

This was a retrospective observational study in which consecutive patients who underwent EPLBD during the defined period were evaluated based on study endpoints.

Research results
----------------

This study confers high safety profile of EPLBD for biliary stone extraction in relation to an EST. The study also ascertains EPLBD as an effective and preferred endoscopic modality than standard endoscopic techniques for complex bile duct stones management. The problems that remain to be solved are the predictive factors indicating the need for EPLBD and factors predicting failure.

Research conclusions
--------------------

EPLBD is a safe and effective technique for biliary stone extraction. Safety of large balloon sphincteroplasty is not influenced by the presence of a periampullary diverticulum or a fresh sphincterotomy. Limited or full sphincterotomy followed by EPLBD does not influence the outcomes. Large and multiple stones may predict need for additional treatment modalities including cholangioscopy and electrohydraulic lithotripsy where large balloon sphincteroplasty remains unsuccessful in achieving duct clearance.

Research perspectives
---------------------

This study suggests that large balloon sphincteroplasty can be performed and repeated safely and effectively in those with a sphincterotomy irrespective of its timing and size to establish complete duct clearance.
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